Niaspan Fct

The usual recommended starting dose of Niaspan FCT (Niacin) extended release is 500 mg at bedtime, after a low-fat snack. The dose is gradually increased every 4 weeks to a maximum dose of 2,000 mg at bedtime. Niaspan FCT (Niacin) extended release should be used in combination with an appropriate exercise program to reduce cholesterol and it is not intended as a substitute for such a program.

Niaspan FCT (Niacin) extended release tablets should be swallowed whole and not crushed or chewed.

Many things can affect the dose of medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones listed here, do not change the way that you are taking the medication without consulting your doctor.

It is important to take Niaspan FCT (Niacin) exactly as prescribed by your doctor. If you miss a dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. If you are not sure what to do after missing a dose, contact your doctor or pharmacist for advice. If you miss taking Niaspan FCT (Niacin) for 7 days or more, contact your doctor for instructions on how to restart taking it.

Store Niaspan FCT (Niacin) at room temperature and keep it out of the reach of children.

Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.

500 mg
Each unscored, medium-orange, film coated tablet printed with “500” on one side contains 500 mg of Niaspan FCT (Niacin) in an extended-release formulation. Nonmedicinal ingredients: methylcellulose, povidone, stearic acid, polyethylene glycol, and the following coloring agents: FD&C Yellow No. 6/Sunset Yellow FCF Aluminum Lake, synthetic red and yellow iron oxides, titanium dioxide, shellac, dehydrated alcohol, isopropyl alcohol, butyl alcohol, propylene glycol, ammonia solution, potassium hydroxide, and black iron oxide.

1000 mg
Each unscored, medium-orange, film coated tablet printed with “1000” on one side contains 1000 mg of Niaspan FCT (Niacin) in an extended-release formulation. Nonmedicinal ingredients: methylcellulose, povidone, stearic acid, polyethylene glycol, and the following coloring agents: FD&C Yellow No. 6/Sunset Yellow FCF Aluminum Lake, synthetic red and yellow iron oxides, titanium dioxide, shellac, dehydrated alcohol, isopropyl alcohol, butyl alcohol, propylene glycol, ammonia solution, potassium hydroxide, and black iron oxide.

Do not take Niaspan FCT (Niacin) if you:

• are allergic to Niaspan FCT (Niacin) or any ingredients of the medication
• have active peptic (stomach or intestine) ulcer disease
• have bleeding
• have severe or unexplained liver or kidney problems or a history of jaundice (yellow skin)

There may be an interaction between Niaspan FCT (Niacin) extended release tablets and any of the following:

• acetylsalicylic acid (ASA)
• alcohol
• bile acid sequestrants (drugs that prevent cholesterol reabsorption by the body; Cholestyramine, Colestipol)
• certain blood pressure medications (e.g., Metoprolol, Propranolol, Verapamil, Diltiazem)
• diabetes medications (e.g., chlorpropamide, glipizide, Glyburide, insulin, Metformin, Nateglinide, Rosiglitazone)
• nitrates (e.g., Nitroglycerin)
• "statin" cholesterol medications (e.g., Atorvastatin, Lovastatin, Simvastatin)
• vitamins or nutritional supplements containing Niaspan FCT (Niacin), nicotinic acid, or nicotinamide
• Warfarin

If you are taking any of these medications, speak with your doctor or pharmacist. Depending on your specific circumstances, your doctor may want you to:

• stop taking one of the medications,
• change one of the medications to another,
• change how you are taking one or both of the medications, or
• leave everything as is.

An interaction between two medications does not always mean that you must stop taking one of them. Speak to your doctor about how any drug interactions are being managed or should be managed.

Medications other than those listed above may interact with Niaspan FCT (Niacin). Tell your doctor or prescriber about all prescription, over-the-counter (non-prescription), and herbal medications you are taking. Also tell them about any supplements you take. Since caffeine, alcohol, the Nicotine from cigarettes, or street drugs can affect the action of many medications, you should let your prescriber know if you use them.

Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Niaspan FCT (Niacin).

Bleeding: Niaspan FCT (Niacin) may cause a reduced number of platelets in the blood, which can make it difficult to stop cuts from bleeding. If you notice any signs of bleeding, such as frequent nosebleeds, unexplained bruising, or black and tarry stools, notify your doctor as soon as possible. Your doctor may order routine blood tests to make sure potential problems are caught early.

Diabetes: People with diabetes may experience higher fasting blood sugar levels. If you have diabetes, your doctor may ask you to monitor your blood sugar more frequently and report any changes in your usual blood sugar patterns to your doctor. Your doctor may need to adjust the doses of your diabetes medications.

Fluid retention: Niaspan FCT (Niacin) may cause fluid retention and swelling, possibly worsening high blood pressure, Congestive Heart Failure, or decreased heart function. If you have these conditions, discuss with your doctor how Niaspan FCT (Niacin) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Niaspan FCT (Niacin), and whether any special monitoring is needed.

If you develop shortness of breath; fatigue; excessive weight gain; chest pain; or swelling of the legs, feet, or ankles while taking Niaspan FCT (Niacin), consult your doctor immediately.

Flushing: Some people taking Niaspan FCT (Niacin) extended release may experience flushing, usually at the start of treatment or when the dose is increased. The flushing usually occurs during the first 8 weeks of treatment and will become milder and less frequent as treatment continues. Flushing usually occurs within 2 to 4 hours after taking a dose and may last a few hours.

Taking the medication at bedtime with a low-fat snack will help you deal with flushing by making it more likely to happen while you are asleep. If flushing wakes you up at night, get up slowly, especially if you are feeling faint or dizzy or if you are taking blood pressure medications.

Avoid alcohol, spicy foods, or hot drinks around the time you take Niaspan FCT (Niacin) extended release, as these may increase flushing. If flushing is bothersome, your doctor may recommend that you take acetylsalicylic acid (Asa), if this is appropriate for you, up to 30 minutes before taking Niaspan FCT (Niacin) extended release.

Gout: Niaspan FCT (Niacin) may cause increased levels of uric acid in the blood, causing flare-ups of gout. If you have gout, discuss with your doctor how Niaspan FCT (Niacin) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Niaspan FCT (Niacin), and whether any special monitoring is needed. Report any joint pain, joint swelling, or warmth to your doctor immediately.

Heart problems: If you have unstable Angina or other heart conditions, discuss with your doctor how Niaspan FCT (Niacin) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Niaspan FCT (Niacin), and whether any special monitoring is needed.

Kidney function: Kidney Disease and reduced kidney function may cause Niaspan FCT (Niacin) to build up in the body and cause an increase in side effects. If you have kidney disease, discuss with your doctor how Niaspan FCT (Niacin) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Niaspan FCT (Niacin), and whether any special monitoring is needed.

Liver disease: On rare occasions, liver damage has occurred in people taking Niaspan FCT (Niacin). If you have liver disease or a large alcohol intake you should be closely monitored by your doctor while taking Niaspan FCT (Niacin) extended release. People with severe or unexplained liver disease should not take Niaspan FCT (Niacin) extended release.

If you experience symptoms of liver problems such as fatigue, feeling unwell, loss of appetite, nausea, yellowing of the skin or whites of the eyes, dark urine, pale stools, abdominal pain or swelling, and itchy skin, contact your doctor immediately.

Restarting the medication: If you need to restart the medication after you have not taken it for a long period of time, check with your doctor first. You may need to restart treatment at a lower dose and gradually increase the dose over time.

Serious warnings and precautions: If you were previously taking another Niaspan FCT (Niacin) tablet, do not start extended-release Niaspan FCT (Niacin) at the same dose. You must start with a lower dose of extended release Niaspan FCT (Niacin) and gradually increase your dose as directed by your doctor.

Do not substitute one Niaspan FCT (Niacin) product for another; improper substitution can cause severe liver disorders.

Stomach problems: Niaspan FCT (Niacin) may cause stomach problems such as ulcers or bleeding. If you have stomach problems, discuss with your doctor how Niaspan FCT (Niacin) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Niaspan FCT (Niacin), and whether any special monitoring is needed.

Call your doctor immediately if you notice signs such as stomach or abdominal pain, black tarry stools, or vomiting blood. Using acetylsalicylic (ASA) to reduce flushing caused by Niaspan FCT (Niacin) may increase the risk of stomach problems.

Pregnancy: Niaspan FCT (Niacin) should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking Niaspan FCT (Niacin), contact your doctor immediately.

Breast-feeding: Niaspan FCT (Niacin) passes into breast milk. If you are a breast-feeding mother and are taking Niaspan FCT (Niacin) extended release, it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.

Children: The safety and effectiveness of using Niaspan FCT (Niacin) have not been established for children.